ONMDWNasdaqServices-Commercial Physical & Biological ResearchUS GAAP · USD

OneMedNet Corp

OneMedNet Corp is a U.S.-based commercial research services company focused on collecting, curating, and delivering medical imaging and related clinical data for research and analytics use. The company operates as a data-enabled services business serving healthcare, life sciences, and other research-oriented customers that need access to de-identified real-world medical data.

Kysy yhtiöstä
Liikevaihto1,4milj. USD
+111,4 %v/v
Liikevoitto (EBIT)−9,7milj. USD
−0,6 %v/v
EBIT-marginaali−711,3%
+782,4 %-yks.v/v
Nettotulos−2,8milj. USD
+72,3 %v/v
Vapaa kassavirta−7,5milj. USD
−7,3 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2021–2025

−10,0−7,5−5,0−2,50,02,5milj. USD2021: EBIT −0,59 milj. USD20212022: 1,2 milj. USD2022: EBIT −7,7 milj. USD20222023: 1,0 milj. USD2023: EBIT −6,9 milj. USD20232024: 0,64 milj. USD2024: EBIT −9,6 milj. USD20242025: 1,4 milj. USD2025: EBIT −9,7 milj. USD20251,4−9,7
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: OneMedNet Corp

Liiketoiminta

Osuus liikevaihdosta
Medical imaging data services45 %

Collection, organization, and delivery of imaging data for research and analytics use.

Clinical data curation30 %

De-identification and structuring of clinical records and related metadata.

Data licensing15 %

Licensing curated datasets to customers for research, model development, and analysis.

Research support services10 %

Project support, data preparation, and related services for research workflows.

Tuotteet

Raportoitu · osuus liikevaihdosta
92,3%FY2025100 %
  • Data Delivery Revenue92,3 %
  • Subscription Revenue7,7 %

Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.

Asiakkaat

OneMedNet’s customers are typically organizations that need high-quality medical data for research, analytics, and product development. These buyers include life sciences companies, healthcare technology firms, and research institutions that value curated, de-identified datasets and the ability to use them in regulated workflows.

Life sciences companies

Buy curated medical data and research support for evidence generation and development programs.

Healthcare technology companies

Use de-identified imaging and clinical data to train, validate, and commercialize analytics tools.

Research institutions

Purchase or access datasets for academic, translational, and clinical research projects.

Healthcare providers and networks

May contribute data or engage for research-oriented data services and collaborations.

Strategia

The company’s strategy is to expand the utility of its medical data platform by increasing the volume, quality, and usability of curated datasets. It also depends on building customer relationships in research and analytics markets where differentiated data access can support recurring demand and broader use cases.

Grow the curated data asset baseKeskipitkä aikaväli

More and better data increases the platform’s value to research customers.

Deepen customer adoption in research marketsKeskipitkä aikaväli

Repeat usage and broader customer penetration support commercialization.

Maintain compliance and data governanceLyhyt aikaväli

Healthcare data businesses depend on privacy, consent, and regulatory trust.

Maantiede

OneMedNet is headquartered in the United States and its business is centered on U.S. healthcare data and research markets. Its operating footprint is tied to access to clinical data sources, healthcare providers, and research customers, so regulatory and data-governance requirements in the U.S. are central to the business.

Riskit

The business depends on access to regulated healthcare data, so privacy, consent, and data-governance failures could materially disrupt operations. It also faces commercialization risk because demand depends on customers’ willingness to adopt curated datasets and on the company’s ability to maintain a differentiated data supply.

Järjestetty vakavuuden mukaan
Healthcare privacy and regulatory complianceKorkea

The company handles sensitive medical data and must meet privacy and de-identification requirements.

KohdistuuData collectionCurationLicensing workflows
Data supply concentration and access riskKorkea

The platform depends on continued access to clinical data sources and contributors.

Kohdistuu: Provider relationships and data ingestion

Commercial adoption riskKeskitaso

Customers must see enough value in the datasets to renew or expand usage.

Kohdistuu: Life sciences and healthcare analytics demand

Competition and substitutionKeskitaso

Other data vendors or internal customer data assets can reduce demand for the company’s offerings.

Kohdistuu: Research data licensing market

Kysy Clarifolta: OneMedNet Corp

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Data licensing and research services may have different timing rules depending on contract terms.

Vaikutus: Can shift revenue between periods and affect comparability.

Contract assets and receivables

Customer billing may not align with service delivery or access periods.

Vaikutus: Affects working capital and credit-loss estimates.

Intangible asset and software impairment

Platform-related assets require judgment on future recoverability.

Vaikutus: Can create non-cash charges if expected cash flows weaken.

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

OneMeta Inc.

ONEI · Services-Computer Processing & Data Preparation

RadNet, Inc.

RDNT · Services-Medical Laboratories

HealthStream, Inc

HSTM · Services-Computer Programming, Data Processing, Etc.

RetinalGenix Technologies Inc.

RTGN · Surgical & Medical Instruments & Apparatus

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

HealthLynked Corp

HLYK · Services-Offices & Clinics of Doctors of Medicine

Päivitetty: 24.9.2026

OneMedNet Corp (ONMDW) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo